GoldenGolden
C16 Biosciences

C16 Biosciences

C16 Biosciences is a biotechnology company making alternatives to palm oil founded in 2017 by Shara Ticku, David Heller and Harry McNamara.

C16 Biosciences is a biotechnology company making alternatives to palm oil that is headquartered in Somerville, Massachusetts and was founded in 2017 by David Heller, Harry McNamara, and Shara Ticku.

C16 was founded with the objective of creating a sustainable, environmentally friendly alternative to palm oil. By offering producers, refiners, traders and consumers of palm oil an opportunity to invest part of their production into bio-based oils and sustainability efforts, their stated aim is to reduce the environmental footprint of palm oil production and protect natural land, wildlife and resources in the process.They have developed technology to brew an alternative to palm oil from microbes.They are brewing palm oil using fermentation.

Funding
Seed

On August 20, 2018 C16 Biosciences announced raising $4 million in seed funding from Y Combinator, Wei Guo, UpHonest Capital, and Soma Capital.

Timeline

March 2020
C16 Biosciences raises a $20,000,000 series A round from Breakthrough Energy Ventures, DCVC, Erik Peterson, Friále, Future Tech Lab, Liquid 2 Ventures, Pioneer Fund, Sound Ventures, Waldencast and Y Combinator.
May 26, 2017
C16 Biosciences was founded by David Heller, Harry McNamara and Shara Ticku.

Funding rounds

People

Name
Role
LinkedIn

David Heller

Employee

Harry McNamara

Employee

Jason Gray

Investor

Shara Ticku

Employee

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
By Manuela Saragosa
December 15, 2020
BBC News
Plantations for palm oil are blamed for rainforest destruction, but an artificial palm oil is close.

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.